Editor's Choice – John Ingram – November 2023.
- Published in:
- 2023
- Publication type:
- Editorial
Works matching IS 00070963 AND DT 2023 AND VI 189 AND IP 5
Results: 17
1
2
Multiple skin lesions, especially on the legs, predict a poorer prognosis in skin lymphoma with large tumour cells.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 5, p. e98, doi. 10.1093/bjd/ljad354
- Publication type:
- Article
3
The effect of extracorporeal photopheresis on cytokines released by leukaemic cutaneous T-cell lymphoma.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 5, p. e97, doi. 10.1093/bjd/ljad358
- Publication type:
- Article
4
Understanding the biology of cutaneous squamous cell carcinoma.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 5, p. e96, doi. 10.1093/bjd/ljad355
- Publication type:
- Article
5
Greater understanding about interpreting the Recap of atopic eczema (RECAP) questionnaire.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 5, p. e95, doi. 10.1093/bjd/ljad359
- Publication type:
- Article
6
Views on vitiligo disease course and treatment among people living with vitiligo and healthcare providers worldwide.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 5, p. e94, doi. 10.1093/bjd/ljad350
- Publication type:
- Article
7
Comparison of biologic treatments in psoriasis using treatment duration.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 5, p. e93, doi. 10.1093/bjd/ljad356
- Publication type:
- Article
8
Lifetime burden of Stevens–Johnson syndrome/toxic epidermal necrolysis.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 5, p. e92, doi. 10.1093/bjd/ljad352
- Publication type:
- Article
9
Comparison of risankizumab with apremilast for the treatment of moderate psoriasis.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 5, p. e91, doi. 10.1093/bjd/ljad349
- Publication type:
- Article
10
Safety and effectiveness of amlitelimab, a potential new treatment for atopic dermatitis: results of a clinical trial.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 5, p. e90, doi. 10.1093/bjd/ljad357
- Publication type:
- Article
11
A new rapamycin cream formulation improves facial angiofibromas.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 5, p. e89, doi. 10.1093/bjd/ljad353
- Publication type:
- Article
12
A study of the safety and effectiveness of lirentelimab as a treatment for people with indolent systemic mastocytosis.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 5, p. e88, doi. 10.1093/bjd/ljad351
- Publication type:
- Article
13
Correction to: TMEM232 promotes the inflammatory response in atopic dermatitis via the nuclear factor-κB and signal transducer and activator of transcription 3 signalling pathways.
- Published in:
- 2023
- Publication type:
- Correction Notice
14
Correction to: The aggressive behaviour of squamous cell carcinoma in epidermolysis bullosa: analysis of clinical outcomes and tumour characteristics in the Dutch EB Registry.
- Published in:
- 2023
- Publication type:
- Correction Notice
15
Correction to: Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study.
- Published in:
- 2023
- Publication type:
- Correction Notice
16
Correction to: Partner bereavement and risk of psoriasis and atopic eczema: cohort studies in the U.K. and Denmark, and to: Partner bereavement and risk of chronic urticaria, alopecia areata and vitiligo: cohort studies in the UK and Denmark.
- Published in:
- 2023
- Publication type:
- Correction Notice
17
Correction to: Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma.
- Published in:
- 2023
- Publication type:
- Correction Notice